Noor El-Hawwat’s journey into the tech industry began with a simple decision to follow in her sister’s footsteps and major in computer science. However, what started as a straightforward choice soon blossomed into a passion for…
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical study by Weill Cornell Medicine investigators.
Misty Copeland, who in 2015 became the first Black woman to be named principal dancer of the American Ballet Theatre, will give the keynote address at Senior Convocation on May 22, from 1-2:30 p.m. in Barton Hall.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
This year's L. Michael Goldsmith Lecture will feature guest speaker Kim Yao, principal at Architecture Research Office. In advance of this annual New York City event, Yao shares a glimpse into her professional trajectory and the talk she has planned for September 25.
Implemented by Cornell Cooperative Extension and partners, SNAP-Ed New York helped hundreds of thousands of low-income New Yorkers improve their diet and overall health every year.
Sakib Jamal ‘19 was recently chosen for the Forbes 30 Under 30 list, in part for his book, The Young VC's Handbook, a tactical guide for newcomers to venture capital.
People with diabetes who were taking GLP-1 receptor agonist drugs had significantly lower rates of hospital readmission, wound reopening and hematoma after surgery, according to new study.
Hospices are increasingly owned by private equity firms and publicly traded companies, but recently Weill Cornell Medicine researchers found that they performed substantially worse than hospices owned by not-for-profit agencies.
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.